piracetam has been researched along with Dystonia in 9 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Dystonia: An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77)
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study, we examined the effects of the two new, high affinity SV2A ligands, brivaracetam and seletracetam, in comparison to levetiracetam on the severity of dystonia in mutant hamsters." | 7.74 | Brivaracetam and seletracetam, two new SV2A ligands, improve paroxysmal dystonia in the dt sz mutant hamster. ( Hamann, M; Richter, A; Sander, SE, 2008) |
| "We report the case of a woman with generalized dystonia whose symptoms improved with the use of levetiracetam." | 7.73 | Levetiracetam for the treatment of generalized dystonia. ( Chari, G; Hauser, RA; Louis, ED; Sullivan, KL; Zesiewicz, TA, 2005) |
| "The effects of the nootropic drug piracetam and its analogue, the antiepileptic drug levetiracetam (ucb L059) on severity of dystonic attacks were studied in a mutant hamster model of idiopathic generalized dystonia." | 7.70 | Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia. ( Löscher, W; Richter, A, 2000) |
| " In the present study, we examined the effects of the two new, high affinity SV2A ligands, brivaracetam and seletracetam, in comparison to levetiracetam on the severity of dystonia in mutant hamsters." | 3.74 | Brivaracetam and seletracetam, two new SV2A ligands, improve paroxysmal dystonia in the dt sz mutant hamster. ( Hamann, M; Richter, A; Sander, SE, 2008) |
| "We report the case of a woman with generalized dystonia whose symptoms improved with the use of levetiracetam." | 3.73 | Levetiracetam for the treatment of generalized dystonia. ( Chari, G; Hauser, RA; Louis, ED; Sullivan, KL; Zesiewicz, TA, 2005) |
| "Secondary paroxysmal dyskinesias (SPDs) are short, episodic, and recurrent movement disorders, classically related to multiple sclerosis (MS)." | 1.46 | Secondary paroxysmal dyskinesia in multiple sclerosis: Clinical-radiological features and treatment. Case report of seven patients. ( Cárcamo-Rodríguez, C; Ciampi, E; Cruz, JP; Godoy-Santín, J; Juri, C; Uribe-San-Martín, R, 2017) |
| "However, dystonia was dramatically improved by a treatment with corticosteroids." | 1.34 | Orofacial dystonia related to Sjogren's syndrome. ( Bonakis, A; Kalfakis, N; Kontaxis, T; Papageorgiou, SG, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciampi, E | 1 |
| Uribe-San-Martín, R | 1 |
| Godoy-Santín, J | 1 |
| Cruz, JP | 1 |
| Cárcamo-Rodríguez, C | 1 |
| Juri, C | 1 |
| Boesebeck, F | 1 |
| Schwarz, O | 1 |
| Dohmen, B | 1 |
| Graef, U | 1 |
| Vestring, T | 1 |
| Kramme, C | 1 |
| Bien, CG | 1 |
| Hamann, M | 1 |
| Sander, SE | 1 |
| Richter, A | 2 |
| Osman, NI | 1 |
| Lorincz, MT | 1 |
| Hulsing, KL | 1 |
| Gebarski, SS | 1 |
| Miyazaki, Y | 1 |
| Sato, K | 1 |
| Koizumi, H | 1 |
| Sako, W | 1 |
| Asanuma, K | 1 |
| Kaji, R | 1 |
| Sullivan, KL | 1 |
| Hauser, RA | 1 |
| Louis, ED | 1 |
| Chari, G | 1 |
| Zesiewicz, TA | 1 |
| Papageorgiou, SG | 1 |
| Kontaxis, T | 1 |
| Bonakis, A | 1 |
| Kalfakis, N | 1 |
| Hering, S | 1 |
| Wenning, GK | 1 |
| Seppi, K | 1 |
| Poewe, W | 1 |
| Mueller, J | 1 |
| Löscher, W | 1 |
1 trial available for piracetam and Dystonia
| Article | Year |
|---|---|
An open trial of levetiracetam for segmental and generalized dystonia.
Topics: Adult; Aged; Anticonvulsants; Dystonia; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Midd | 2007 |
8 other studies available for piracetam and Dystonia
| Article | Year |
|---|---|
Secondary paroxysmal dyskinesia in multiple sclerosis: Clinical-radiological features and treatment. Case report of seven patients.
Topics: Acetazolamide; Adult; Anticonvulsants; Cerebellum; Clonazepam; Dyskinesias; Dystonia; Female; Follow | 2017 |
Faciobrachial dystonic seizures arise from cortico-subcortical abnormal brain areas.
Topics: Adult; Anticonvulsants; Autoantibodies; Autoantigens; Brain; Dystonia; Female; Functional Laterality | 2013 |
Brivaracetam and seletracetam, two new SV2A ligands, improve paroxysmal dystonia in the dt sz mutant hamster.
Topics: Animals; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Dystonia; Humans; Lev | 2008 |
Leukoencephalopathy, cerebral calcifications, and cysts: case report.
Topics: Adult; Anticonvulsants; Basal Ganglia Diseases; Brain; Calcinosis; Central Nervous System Cysts; Dys | 2012 |
[New medications for dystonia].
Topics: Anticonvulsants; Dystonia; GABA-A Receptor Agonists; Humans; Levetiracetam; Piracetam; Pyridines; Zo | 2012 |
Levetiracetam for the treatment of generalized dystonia.
Topics: Anticonvulsants; Blepharospasm; Dystonia; Female; Humans; Levetiracetam; Middle Aged; Piracetam | 2005 |
Orofacial dystonia related to Sjogren's syndrome.
Topics: Adrenal Cortex Hormones; Brain; Clonazepam; Dystonia; Dystonic Disorders; Face; Female; Humans; Leve | 2007 |
Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia.
Topics: Animals; Anticonvulsants; Cricetinae; Dystonia; Levetiracetam; Mutation; Nootropic Agents; Piracetam | 2000 |